Literature DB >> 2329417

Respiratory virus infection as a cause of prolonged symptoms in acute otitis media.

M Arola1, T Ziegler, O Ruuskanen.   

Abstract

We studied respiratory viruses in 22 children with acute otitis media who had failed to improve after at least 48 hours of antimicrobial therapy. The mean duration of preenrollment antimicrobial therapy was 4.8 days. For comparison we studied 66 children with newly diagnosed acute otitis media. Respiratory viruses were isolated from middle ear fluid or from the nasopharynx, or both, significantly more often in the patients unresponsive to initial antimicrobial therapy than in the comparison patients (68% vs 41%, p less than 0.05). Viruses were recovered from the middle ear fluid in 32% of the study patients and from 15% of the comparison group. Bacteria were isolated from the middle ear fluid of four (18%) children in the study group; one child had an isolate resistant to initial antimicrobial therapy. All four children with bacteria in the middle ear fluid had evidence of concomitant respiratory virus infection. Our results indicate that respiratory virus infection is often present in patients with acute otitis media unresponsive to initial antimicrobial therapy, and may explain the prolongation of symptoms of infection. Resistant bacteria seem to be a less common cause of failure of the initial treatment.

Entities:  

Mesh:

Year:  1990        PMID: 2329417     DOI: 10.1016/s0022-3476(05)82650-2

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  22 in total

Review 1.  Current research on respiratory viral infections: Third International Symposium.

Authors:  A C Schmidt; R B Couch; G J Galasso; F G Hayden; J Mills; B R Murphy; R M Chanock
Journal:  Antiviral Res       Date:  2001-06       Impact factor: 5.970

2.  Detection of rhinovirus in sinus brushings of patients with acute community-acquired sinusitis by reverse transcription-PCR.

Authors:  A Pitkäranta; E Arruda; H Malmberg; F G Hayden
Journal:  J Clin Microbiol       Date:  1997-07       Impact factor: 5.948

3.  Impact of respiratory viral infections on α-hemolytic streptococci and otopathogens in the nasopharynx of young children.

Authors:  Victoria Friedel; Arthur Chang; Jennifer Wills; Roberto Vargas; Qingfu Xu; Michael E Pichichero
Journal:  Pediatr Infect Dis J       Date:  2013-01       Impact factor: 2.129

4.  Evaluation of potential factors contributing to microbiological treatment failure in Streptococcus pyogenes pharyngitis.

Authors:  S M Kuhn; J Preiksaitis; G J Tyrrel; T Jadavji; D Church; H D Davies
Journal:  Can J Infect Dis       Date:  2001-01

Review 5.  Current research on respiratory viral infections: Fourth International Symposium.

Authors:  Michael G Ison; John Mills; Peter Openshaw; Maria Zambon; Albert Osterhaus; Frederick Hayden
Journal:  Antiviral Res       Date:  2002-08       Impact factor: 5.970

Review 6.  The microbiology of acute and chronic sinusitis and otitis media:a review.

Authors:  P B van Cauwenberge; A M Vander Mijnsbrugge; K J Ingels
Journal:  Eur Arch Otorhinolaryngol       Date:  1993       Impact factor: 2.503

7.  Effect of Streptococcus pneumoniae and influenza A virus on middle ear antimicrobial pharmacokinetics in experimental otitis media.

Authors:  G H Jossart; D M Canafax; G R Erdmann; M J Lovdahl; H Q Russlie; S K Juhn; G S Giebink
Journal:  Pharm Res       Date:  1994-06       Impact factor: 4.200

Review 8.  Importance of respiratory viruses in acute otitis media.

Authors:  Terho Heikkinen; Tasnee Chonmaitree
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

9.  Acute otitis media during the first two years of life in a rural community in Bangladesh: a prospective cohort study.

Authors:  Eliza Roy; Kh Zahid Hasan; Fazlul Haque; A K M Siddique; Richard Bradley Sack
Journal:  J Health Popul Nutr       Date:  2007-12       Impact factor: 2.000

Review 10.  Immunopathogenesis of polymicrobial otitis media.

Authors:  Lauren O Bakaletz
Journal:  J Leukoc Biol       Date:  2009-10-20       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.